Case report fatal anaerobic pulmonary infection due to Bifidobacterium eriksonii

Green, Stephen L.

doi:10.1080/00325481.1978.11714790

Cited by 17 publications

(9 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pathogen: female genital tract abscess, UTI in renal transplant recipients Domann et al, 2003;Citron et al, 2007 Bifidobacterium longum Opportunistic pathogen (genus): abscess Green, 1978;Cryan et al, 1991;Cannon et al, 2005 specimens of two women we detected two pathogens, Lactobacillus sp. and G. vaginalis (Fig.…”

Section: Anaerococcus Lactolyticusmentioning

confidence: 71%

Hidden pathogens uncovered: metagenomic analysis of urinary tract infections

et al. 2008

View full text Add to dashboard Cite

Summary Urinary tract infections (UTIs) are the most common kidney and urologic diseases in industrial nations and are usually caused through faecal contamination of the urinary tract. In this study, we have examined 1449 urine specimens both by culture and by PCR. The majority of UTIs examined were caused by Escherichia coli (35.15%), followed by miscellaneous bacteria (23.03%), and by Enterococcus faecalis (19.39%). A large fraction of fastidious and anaerobic bacteria (22.43%) was not detected under culture conditions but only by using PCR. This group of bacteria evade the standard culture conditions used in routine diagnostic laboratories examining urine specimens. The molecular approach used broad‐range 16S rDNA PCR, denaturing high‐performance liquid chromatography analysis, sequencing, and bioinformatic analysis to uncover these ‘hidden’ pathogens and is recommended in particular when examining leukocyte esterase‐positive and culture‐negative urinary tract specimens.

show abstract

Section: Anaerococcus Lactolyticusmentioning

confidence: 71%

Hidden pathogens uncovered: metagenomic analysis of urinary tract infections

et al. 2008

View full text Add to dashboard Cite

show abstract

“…There are case reports of Bifidobacterium as the causative agent in necrotising pancreatitis9 sepsis10 epidural abscess11 fatal pulmonary infection12 and dental caries 1. Other cases may remain undiagnosed since Bifidobacterium is considered normal flora and potentially could be dismissed as a contaminant in laboratory specimens.…”

Section: Discussionmentioning

confidence: 99%

Bifidobacterium—friend or foe? A case of urinary tract infection withBifidobacteriumspecies

2014

View full text Add to dashboard Cite

Bifidobacterium-a commensal of the human intestine is considered non-pathogenic and has been advocated as a probiotic due to its potential beneficial effects. However, there have been case reports implicating bifidobacteria as pathogenic agents in a variety of different infectious conditions. We discuss here one such case of a complicated urinary tract infection associated with Bifidobacterium spp.

show abstract

“…Isolated cases of B. dentium (previously B. eriksonii ) infections have been reported in adults (59,60). Furthermore, Bidifobacterium sp.…”

Section: Other Infectionsmentioning

confidence: 97%

Safety Aspects of Lactobacillus and Bifidobacterium Species Originating from Human Oro-gastrointestinal Tract or from Probiotic Products

Saarela

Mättö

Mattila‐Sandholm

2002

Microbial Ecology in Health and Disease

View full text Add to dashboard Cite

Probiotics are live microbial preparations, which have documented health benefits for the consumers by maintaining or improving their intestinal microbiota balance. Established probiotic effects include improved lactose digestion, modulation of gut microbiota, immune modulation, reduced duration of rotavirus diarrhoea, changes in biomarkers such as harmful faecal enzyme activities, alleviation of atopic dermatitis symptoms in babies, and positive effects against superficial bladder cancer and cervical cancer. Most bacteria that have probiotic properties belong to the genera Lactobacillus and Bifidobacterium. Since probiotic consumption involves ingestion of large numbers of viable bacterial cells (daily dosage between log 9 and log 11 CFU) safety aspects of probiotic consumption are of utmost importance. Knowledge on the survival of probiotics in the GI-tract, their translocation and colonisation properties and the fate of probiotic-derived active components is important for the evaluation of possible negative and positive effects of probiotic consumption. Assessing the risks of probiotic consumption can be a very expensive and time-consuming task. While considering the risk of probiotic consumption we have to keep in mind that lactic acid bacteria have been globally consumed in a myriad of fermented food varieties (milk, meat, vegetable and cereal products) for a very long time without an indication that they could be generally harmful to the consumers' health. In Finland lactobacilli strains isolated from bacteremia have been systematically characterised. Although the yearly consumption of probiotic products containing lactobacilli has increased during the last 10 years, the incidence of lactobacillemia has not increased. There is one local infection case with an indistinguishable isolate to L. rhamnosus GG. The extensive follow-up period indicates that the risk of serious infection by one single probiotic strain is very low. Simultaneously, it is difficult to estimate all the health benefits the same probiotic strain has implemented, also in immunocompromised patients. However, no live bacterium can be guaranteed for a zero risk in each individual host since the outcome of bacterial ingestion (passage through GI-tract, colonisation, infection) is determined both by the host and the bacterium.

show abstract

Case report fatal anaerobic pulmonary infection due to Bifidobacterium eriksonii

Cited by 17 publications

References 6 publications

Hidden pathogens uncovered: metagenomic analysis of urinary tract infections

Hidden pathogens uncovered: metagenomic analysis of urinary tract infections

Bifidobacterium—friend or foe? A case of urinary tract infection withBifidobacteriumspecies

Safety Aspects of Lactobacillus and Bifidobacterium Species Originating from Human Oro-gastrointestinal Tract or from Probiotic Products

Contact Info

Product

Resources

About